Woodmont Investment Counsel LLC maintained its position in Stryker Corporation (NYSE:SYK) during the first quarter, Holdings Channel reports. The firm owned 5,085 shares of the medical technology company’s stock at the end of the first quarter. Woodmont Investment Counsel LLC’s holdings in Stryker Corporation were worth $609,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. UBS Asset Management Americas Inc. increased its position in Stryker Corporation by 1.7% in the fourth quarter. UBS Asset Management Americas Inc. now owns 929,571 shares of the medical technology company’s stock valued at $111,370,000 after buying an additional 15,523 shares during the period. M Holdings Securities Inc. increased its position in Stryker Corporation by 10.9% in the fourth quarter. M Holdings Securities Inc. now owns 8,074 shares of the medical technology company’s stock valued at $967,000 after buying an additional 793 shares during the period. Becker Capital Management Inc. increased its position in Stryker Corporation by 6.6% in the fourth quarter. Becker Capital Management Inc. now owns 3,222 shares of the medical technology company’s stock valued at $386,000 after buying an additional 200 shares during the period. Teachers Advisors LLC increased its position in Stryker Corporation by 5.7% in the fourth quarter. Teachers Advisors LLC now owns 377,336 shares of the medical technology company’s stock valued at $45,209,000 after buying an additional 20,450 shares during the period. Finally, Kentucky Retirement Systems bought a new position in Stryker Corporation during the fourth quarter valued at approximately $2,702,000. 74.25% of the stock is owned by institutional investors and hedge funds.
Shares of Stryker Corporation (SYK) opened at 146.19 on Monday. The company has a 50-day moving average of $142.05 and a 200-day moving average of $132.85. The stock has a market capitalization of $54.64 billion, a price-to-earnings ratio of 32.85 and a beta of 0.79. Stryker Corporation has a 52-week low of $106.48 and a 52-week high of $148.15.
Stryker Corporation (NYSE:SYK) last posted its earnings results on Tuesday, April 25th. The medical technology company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.43 by $0.05. The company had revenue of $2.96 billion for the quarter, compared to analyst estimates of $2.90 billion. Stryker Corporation had a net margin of 14.33% and a return on equity of 24.26%. Stryker Corporation’s revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.24 EPS. Equities research analysts anticipate that Stryker Corporation will post $6.43 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Monday, July 31st. Shareholders of record on Friday, June 30th will be issued a $0.425 dividend. The ex-dividend date of this dividend is Wednesday, June 28th. This represents a $1.70 annualized dividend and a yield of 1.16%. Stryker Corporation’s payout ratio is 38.20%.
ILLEGAL ACTIVITY WARNING: “Stryker Corporation (SYK) Stake Maintained by Woodmont Investment Counsel LLC” was posted by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://transcriptdaily.com/2017/07/24/stryker-corporation-syk-stake-maintained-by-woodmont-investment-counsel-llc.html.
Several research analysts have commented on SYK shares. Oppenheimer Holdings, Inc. set a $135.00 price objective on shares of Stryker Corporation and gave the company a “hold” rating in a report on Saturday, April 8th. BMO Capital Markets reissued a “hold” rating and set a $125.00 price objective on shares of Stryker Corporation in a report on Tuesday, April 11th. Jefferies Group LLC reissued a “hold” rating and set a $132.00 price objective on shares of Stryker Corporation in a report on Thursday, April 13th. Piper Jaffray Companies reissued an “overweight” rating and set a $148.00 price objective on shares of Stryker Corporation in a report on Monday, April 17th. Finally, Needham & Company LLC reissued a “sell” rating on shares of Stryker Corporation in a report on Wednesday, April 26th. Three analysts have rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the stock. Stryker Corporation currently has an average rating of “Hold” and an average target price of $140.13.
In other Stryker Corporation news, insider Timothy J. Scannell sold 13,322 shares of the business’s stock in a transaction dated Tuesday, May 2nd. The shares were sold at an average price of $135.89, for a total value of $1,810,326.58. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider David Floyd sold 7,381 shares of the business’s stock in a transaction dated Monday, June 5th. The shares were sold at an average price of $144.70, for a total transaction of $1,068,030.70. The disclosure for this sale can be found here. Insiders sold a total of 40,008 shares of company stock worth $5,669,088 over the last quarter. 7.40% of the stock is currently owned by company insiders.
Stryker Corporation Company Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.